Class IIReported 2025-11-05

Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-09

Recalled by ProRx LLC

Reason for Recall

Lack of Assurance of Sterility

Recall Number

D-0117-2026

Classification

Class II

Status

Ongoing